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Introduction: Obesity constitutes a serious global health concern reaching pandemic prevalence rates.
The existence of functional brown adipose tissue (BAT) in adult humans has provoked intense research
interest in the role of this metabolically active tissue in whole-body energy balance and body weight reg-
ulation. A number of environmental, physiological, pathological, and pharmacological stimuli have been
proposed to induce BAT-mediated thermogenesis and functional thermogenic BAT-like activity in white
adipose tissue (WAT), opening new avenues for therapeutic strategies based on enhancing the number of
beige adipocytes in WAT.
Hypothesis: Recent evidence support a role of L-menthol cooling, mediated by TRPM8 receptor, on UCP1-
dependent thermogenesis and BAT-like activity in classical WAT depots along with the recruitment of
BAT at specific anatomical sites. L-Menthol-induced BAT thermogenesis has been suggested to occur by
a b-adrenergic-independent mechanism, avoiding potential side-effects due to extensive b-adrenergic
stimulation mediated by available beta receptor agonists. L-Menthol has been also linked to the activation
of the cold-gated ion channel TRPA1. However, its role in L-menthol-induced UCP1-dependent thermo-
genic activity in BAT and WAT remains undetermined. White adipose tissue plasticity has important clin-
ical implications for obesity prevention and/or treatment because higher levels of UCP1-dependent
thermogenesis can lead to enhanced energy expenditure at a considerable extent. We hypothesize that
chronic dietary L-menthol treatment could induce TRPM8- and TRPA1-dependent WAT adaptations,
resembling BAT-like activity, and overall improve whole-body metabolic health in obese and overweight
individuals.
Conclusions: The putative impact of chronic L-menthol dietary treatment on the stimulation of BAT-like
activity in classical WAT depots in humans remains unknown. A detailed experimental design has been
proposed to investigate the hypothesized L-menthol-induced browning of WAT. If our hypothesis was to
be confirmed, TRPM8/TRPA1-induced metabolic adaptations of WAT to BAT-like activity could provide a
promising novel therapeutic approach for increasing energy expenditure, regulating body weight, and
preventing obesity and its related co-morbidities in humans.
 2016 Elsevier Ltd. All rights reserved.
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Obesity and its related disorders represent major global health
concerns. The World Health Organization estimates that the global
prevalence of obesity has doubled since 1980 [1]. In 2014 the
prevalence of overweight adults reached more than 1.9 billion,
with 600 million of these being obese. Increased obesity and over-
weight prevalence rates are also recorded in children aged below
5 years reaching 42 million in 2013 [1]. Treating obesity, however,
has proven to be a complex endeavor that has been mostly unsuc-
cessful [2,3], supporting its epidemic prevalence rates in children
and adults [1,4,5]. Therefore, novel therapeutic strategies are war-
ranted for preventing and/or combating this health threatening
condition.
The relatively recent discovery of functional brown adipose tis-
sue (BAT) in adult humans has provoked a plethora of theories and
experiments on the metabolic capabilities of BAT and its potential
for the prevention and/or treatment of obesity and obesity-
associated diseases, including type 2 diabetes, cardiovascular dis-
ease, and several cancers [6,7]. In human adults, BAT is found
mainly in the cervical, supraclavicular, and paravertebral regions,
while in infants it is located also in the interscapular and perirenal
regions [8]. BAT is responsible for non-shivering thermogenesis
(NST), an adaptive mechanism to maintain body temperature
against cold environments by generating heat without shivering
[7,9], mediated by increased uncoupling protein 1 (UCP1) activity.
UCP1 is a mitochondrial transmembrane protein located in the
inner mitochondrial membrane of brown adipocytes that enhances
proton conductivity and provides an alternative pathway by which
protons can re-enter the mitochondrial matrix. In most eukaryotic
cells during cellular respiration, the protons that are normally
pumped across the mitochondrial inner membrane due to the
NADH and FADH2 oxidation generate an electrochemical gradient
that is dissipated as they enter the mitochondrial matrix through
ATP synthase resulting in ATP production. However, the presence
of UCP1 in brown adipocytes provides a different biochemical
pathway in these cells allowing protons to return to the mitochon-
drial matrix through UCP1 instead of ATP synthase. During this
process, the energy of the electrochemical gradient is dissipated
as heat [7,9].
Similarly to brown adipocytes, UCP1 is also expressed in a dis-
tinct type of adipocytes which are termed as beige adipocytes [ex-
tensively reviewed in [8,10–12]. Beige adipocytes, however,
express a different gene pattern (e.g. transcription factors) than
classical brown adipocytes [13–15]. Although beige adipocytes
are characterized by BAT functional thermogenic properties (i.e.,
UCP1 expression and norepinephrine-induced thermogenesis)
and are located in classical white adipose tissue (WAT), they are
developmentally distinct from both brown and white fat precur-
sors. Rodent studies proposed that only a subpopulation of beige
adipocytes are located within WAT depots [13,16–18] exhibiting
increased UCP1 activity in response to a number of stimuli, includ-
ing cold exposure [19,20], b-adrenergic stimulation [16–18,21,22],
peroxisome proliferator-activated receptor (PPARc)-agonist stimu-
lation [13,23–28], forced [14,29–32], or voluntary exercise [30].
Substantial evidence supports the putative role for BAT-
mediated NST in increasing energy expenditure and regulating
energy metabolism [33–36]. Indeed, the energy expended for heat
production during prolonged and consistent BAT activity may be
sufficient enough to regulate body weight and prevent obesity
and its related comorbidities [7,37]. Despite these beneficial
effects, current evidence suggests that BAT levels steadily decline
with age and that BAT is less active in obese individuals [38,39].
Furthermore, studies in rodent (both in vitro and in vivo) and
human (only in vitro) models have proposed a role for L-mentholin UCP1-NST stimulation and BAT-like activity, mediated by
TRPM8 (transient receptor potential melastatin 8) [40–42].
L-Menthol is a chemical cooling agent naturally produced from
mint oils or prepared synthetically [43] and also an agonist of the
cold sensor TRPM8 [reviewed in [44]]. TRPM8 is predominantly
located in a subpopulation of sensory neurons from dorsal root
ganglia and trigeminal ganglia [45–47]. Interestingly, TRPM8
expression has also been recently discovered in brown and white
adipocytes associated with an increase in UCP1 activation upon
L-menthol administration [41,42]. Specifically, a dose-dependent
effect of menthol on UCP1 protein expression has been demon-
strated in brown adipocytes isolated from wild type mice, but
not in those from TRPM8-deficient mice [41]. Studies on human
white adipocytes cultured with L-menthol showed an increase in
TRPM8 activation and UCP1-dependent thermogenesis, as evi-
denced by an increase in intracellular Ca2+, UCP1 mRNA and pro-
tein levels, mitochondrial membrane potential, mitochondria
number, heat production, basal and insulin stimulated glucose
uptake [42]. In vivo studies on mice showed that 7-month L-
menthol dietary treatment promoted TRPM8-mediated UCP1 acti-
vation in BAT through Ca2+-dependent protein kinase A (PKA)
phosphorylation, increased energy expenditure, improved glucose
metabolism and protected against high-fat diet-induced obesity
[41]. In addition, L-menthol skin application in mice activated
TRPM8 and induced behavioral heat-gain responses, including
increased NST, oxygen consumption and core body temperature
[40]. The effects of L-menthol-induced stimulation of TRPM8 on
UCP1-depedent thermogenesis mimic those thermoregulatory
effects of cold exposure on BAT activity [48–51]. These findings
are corroborating a putative role of L-menthol for the activation
of b-adrenergic-independent signaling pathways mediated by
TRPM8, regulating thermogenesis and metabolic homeostasis.
In vitro and in vivo studies in rodents have demonstrated that L-
menthol activates the cold-gated ion channel TRPA1 (transient
receptor potential ankyrin subtype 1 protein; reviewed in [52])
[53–55], although its role in mediating L-menthol-induced cold
sensitivity has been disputed by others using also rodent animal
[56] and cellular models [57]. Recently, a human study showed
that concomitant activation of TRPA1 and TRPM8 following the
simultaneous topical application of trans-cinnamaldehyde (TRPA1
activator) and L-menthol (TRPM8 activator) induced cold allodynia
and hyperalgesia. These thermal responses were similar to those
observed following the topical application of L-menthol alone, indi-
cating a less pronounced role of TRPA1 in cold hypersensitivity and
transduction [58].
It is evident that the putative role for TRPA1 in cold transduc-
tion remains an intense subject of debate. Recently, Chen et al.
reported a species-dependent difference in TRPA1-mediated cold
or L-menthol sensitivity, based on a single residue difference in
S5 transmembrane domain of the TRPA1 receptor [59]. Rodent
TRPA1 channels are activated by cold and not L-menthol, while
human TRPA1 channels exhibit sensitivity to menthol but not cold
[53,54,60]. Thus, it is intriguing to hypothesize that human TRPA1
could also contribute to L-menthol-induced UCP1-NST activation in
WAT. Up to date, the putative relationship between TRPA1, L-
menthol, and metabolic changes in BAT and WAT still remain to
be firmly established.
Currently, the factors and the molecular mechanisms responsi-
ble for the recruitment of beige adipocytes in human classical WAT
depots, a process known as ‘browning’, and the extent to which
human beige cell development may occur remains to be fully
understood. However, it is evident that the potential of enhancing
the number and the UCP1 activation of beige adipocytes in
WAT provides a promising method for increasing energy expendi-
ture, regulating body weight, and preventing obesity and
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cooling effects of L-menthol on UCP1-mediated thermogenesis
and enhanced number of beige adipocytes in BAT and WAT has
prompted us to hypothesize that chronic dietary L-menthol treat-
ment could induce WAT adaptations, resembling BAT-like activity,
and overall improve whole-body metabolic health in obese and
overweight individuals.The hypothesis
Experimental studies in rodent models and human adipocytes
indicate a potential role of L-menthol-induced TRPM8 activation
in regulating core body temperature, UCP1-dependent NST, resting
metabolic rate, energy expenditure, and glucose metabolism [40–
42,61]. These findings implicate a putative contribution of L-
menthol in BAT thermogenic capacity, a promising therapeutic
regime to combat diet-induced obesity, not yet sufficiently studied
in humans. Furthermore, the increased number of beige adipocytes
in WAT and the UCP1 activation in response to physiological and
pharmacologically-induced stimuli has attracted increased scien-
tific attention as a novel therapeutic regime for combating obesity.
It is, thus, intriguing to hypothesize that TRPM8 and TRPA1 activa-
tion, mediated by chronic dietary L-menthol treatment, could
induce WAT adaptations that resemble BAT-like activity, and over-
all improve whole-body metabolic health in obese and overweight
individuals (Fig. 1).Evaluation of the hypothesis
Transient receptor potential (TRP) ion channels have been pro-
posed to be the principal sensors of thermal stimuli in the periph-
eral nervous system [62,63]. TRPM8 is a temperature- and L-
menthol-sensitive receptor, member of the TRPM subfamily
[44,52,64], which appears to play an important role in thermoreg-
ulation [61]. A number of studies have suggested a physiological
role of L-menthol-induced TRPM8 activation in UCP1-dependent
thermogenesis in BAT and WAT, as listed in Table 1. Interestingly,
long-term TRPM8 activation following dietary L-menthol was pro-
posed to enhance BAT UCP1-dependent thermogenesis in wild type
but not in TRM8-deficient mice, as evident by the enhanced UCP1
expression, energy expenditure, resting metabolic rate, and core
body temperature only in wild type mice [41]. Further, chronic L-
menthol dietary treatment prevented against obesity and
improved glucose abnormal metabolism in mice on high-fat diet,
with an increase in TRPM8-mediated UCP1 expression in BAT but
not in WAT. On the other hand, L-menthol’s cooling effects on
UCP1-dependent thermogenesis were not observed in TRPM8-
deficient mice, indicative of a physiological role of TRPM8 in the
regulation of BAT activity and energy balance [41].
Evidence from human studies suggests a putative role of L-
menthol-induced TRPM8 activation in WAT browning. Specifically,
in vitro L-menthol stimulation of human white adipocytes induced
TRPM8-dependent increased UCP1 expression, heat production,
mitochondria number, mitochondrial membrane potential, and
glucose uptake [42]. These findings indicate that TRPM8 stimula-
tion could induce WAT adaptations to a BAT-like activity in
response to L-menthol’s cooling effects, a promising therapeutic
target to regulate body weight and metabolic homeostasis. Our
group showed that a single oral L-menthol administration gener-
ated minor effects on enhancing thermogenesis and metabolic rate
in humans compared to a single skin L-menthol administration
[37]. However, L-menthol absorption in the body was very high fol-
lowing the oral administration, thus it is logical to hypothesize that
human metabolism and WAT thermogenic activity may increasefollowing a long-term L-menthol oral administration. In this light,
further studies are required to confirm whether daily L-menthol
oral administration is promising candidate treatment for metabolic
disease.
Another intriguing, yet controversial, issue is the role of TRPA1
in L-menthol-induced noxious cold transduction [55,56,58]. Gentry
et al. reported that TRPM8-deficient mice showed L-menthol-
induced cold hypersensitivity in response to intraplantar L-
menthol injection, while TRPA1-null mice did not show this effect,
supporting a role for TRPA1 in mediating L-menthol’s effect on nox-
ious cold sensation [55]. Conversely, Knowlton et al. demonstrated
reduced neural responses to noxious cold stimuli as induced by
intraplantar L-menthol injection in mice lacking TRPM8 channels,
while TRPA1-deficient mice showed L-menthol-mediated neural
activity comparable to wild-type mice [56]. These findings indicate
that TRPA1 ion channel does not play a major role in noxious cold
transduction. In humans, TRPA1-independent behavioral
responses to L-menthol-induced cold hypersensitivity (cold allody-
nia and hyperalgesia), following a single topical L-menthol skin
application, have been recently reported [58]. This discrepancy
with the aforementioned results could be attributed to different
experimental conditions, including species under study (human
subjects or transgenic mice), L-menthol concentration and route
of administration, as well as behavior, neural and thermal sensitiv-
ity assessment tests. Further investigation is thus necessary to elu-
cidate the role for TRPA1 in noxious cold sensing following L-
menthol administration.
To our knowledge, no human studies have been conducted so
far to assess the impact of chronic L-menthol dietary treatment
on UCP1-dependent thermogenesis in WAT and metabolism in
obese and overweight individuals. To provide robust evidence for
our L-menthol-induced WAT browning hypothesis, we are propos-
ing a chronic L-menthol dietary intervention in physically inactive
overweight and obese volunteers. The daily dose of orally adminis-
tered L-menthol must remain within the tolerable upper intake
levels to humans [65]. Participants will be also asked to assess
thermal comfort and sensation following L-menthol oral adminis-
tration, based on previously established scales [66]. To examine
whether L-menthol-induced TRPM8 and TRPA1 activation can pro-
mote UCP1-dependent thermogenesis in subcutaneous WAT, his-
tological and immunohistochemical analyses of WAT biopsies
will be performed to detect the presence of beige adipocytes, as
well as the protein expression of UCP1, TRPM8 and TRPA1. Further,
to determine whether L-menthol-dependent chronic activation of
TRPM8 and TRPA1 regulate WAT metabolic adaptation to BAT-
like thermogenic activities, the expression, both at mRNA and pro-
tein levels, of key genes involved in the browning process and
human metabolism will be assessed. The former genes include
PPARc, placenta-specific 8 (Plac8), retinaldehyde dehydrogenase
1 (Rald), and natriuretic peptide receptor A (NPRA), while the latter
ones to be studied include leptin, adiponectin, fatty acid-binding
protein 3 (FABP3), peroxisome proliferator-activated receptor-
gamma coactivator 1 alpha (PGC-1a), peroxisome proliferator-
activated receptor alpha (PPARa), phosphoglycerate kinase 1
(PGK1), solute carrier family 2, facilitated glucose transporter
member 5 (SLC2A5), glucose transporter type 4 (GLUT4), and cyto-
chrome C oxidase subunit IV isoform 1 (COX4i1).
The potential metabolic effects of L-menthol can be determined
by partitional calorimetry, resting metabolic rate, glucose metabo-
lism. Also, to identify the receptor(s) involved in the L-menthol-
induced adaptive thermogenesis and increased metabolism, the
expression of TRPM8 and TRPA1 may be assessed in white adipo-
cytes both at mRNA and protein levels.
L-Menthol constitutes a novel activator of UCP1 in both BAT and
WAT through the stimulation of TRPM8, independently of b-
adrenergic signaling pathway, avoiding systemic side-effects
Fig. 1. Chronic L-menthol-induced WAT browning hypothesis model in humans. L-Menthol-induced browning of WAT hypothesis model is presented whereby chronic L-
menthol dietary treatment can activate cold-sensitive TRPM8 receptors located on the cell membrane of human white adipocytes, thus inducing an intracellular [Ca2+]
increased and browning of WAT. Recent findings have proposed that L-menthol-mediated TRPM8 stimulation occurs in a Ca2+-dependent protein kinase A (PKA)
phosphorylation mechanism in brown adipocytes. A similar mechanism of L-menthol action in white adipocytes has yet to be determined. Enhanced adaptive UCP1-
dependent thermogenesis in WAT can be associated with a number of thermogenic and metabolic processes, including increased UCP1 expression, heat production, oxygen
consumption, energy expenditure, glucose uptake, and insulin sensitivity. Moreover, L-menthol has been also linked to the activation of the cold-gated ion channel TRPA1.
Thus, similar results may occur whether TRPA1 is expressed on the cell membrane of human white adipocytes and exhibits sensitivity to L-menthol. The involvement of
TRPA1 in L-menthol-induced human WAT browning remains undetermined. If our hypothesis was to be confirmed, L-menthol-induced metabolic adaptations from WAT to
BAT-like activity might provide a safe and efficient therapeutic agent for the development of novel strategies for obesity prevention and/or treatment.
Table 1
Studies indicating the role of L-menthol-mediated TRPM8 activation in UCP1-dependent thermogenesis in BAT and WAT browning.
Study Species/cellular models L-Menthol administration UCP1
thermogenesis
in BAT
UCP1
thermogenesis
in WAT
Molecular pathway
Tajino et al. [40] In vivo TRPM8 (+/+) mice Whole trunk skin application
(10% L-menthol)
Yes ND ND
Ma et al. [41] In vitromature brown adipocytes
isolated from C57BL/6J mice
Stimulation of cultured
adipocytes (30, 100, 300 mM L-
menthol)
Yes No Ca2+-dependent PKA phosphorylation
with no b-adrenergic-stimulation
In vivo C57BL/6J mice Chronic diet (chow diet + 0.5% L-
menthol)
Yes No
Rossato et al.[42] In vitro human differentiated
white adipocytes
Stimulation of cultured
adipocytes (100 lM L-menthol)
Yes ND ND
Note: UCP1 = uncoupling protein 1; BAT = brown adipose tissue; WAT = white adipose tissue; TRPM8 = transient receptor potential cation channel, subfamily M, member 8;
ND = not determined, PKA = protein kinase A.
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also the contribution of TRPA1 cold sensor to L-menthol’s overall
effect on BAT and WAT metabolic adaptations. Identifying putative
factors and biological processes involved in L-menthol-induced
browning effects on WAT could be critical to: (a) gain further
knowledge on the role of this chemical cooling agent in metabolic
homeostasis and its impact on human metabolic health, and (b)
design novel and safe therapeutic strategies against obesity and
its related co-morbidities.Consequences of the hypothesis
An alarmingly high incidence of obesity has been recorded
worldwide representing a serious public health concern with dev-
astating impacts not only on life expectancy but also on health care
economy [67,68]. Recent reports predict that the global market for
drugs treating obesity will reach 5.3 million dollars by 2019 [3].
Despite the growing cost spent on anti-obesity agents, health
professionals continue to express concern that the drugs fail to
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nied with serious side effects [2,3]. The recent discovery of func-
tional BAT in human adults [33,34,51,69] has attracted much
research attention as a therapeutic agent for treating obesity.
In humans, cold exposure has long been used to stimulate BAT
thermogenic capacity [70–73], which may occur through activa-
tion of sympathetic nervous system (SNS) [70,74]. Extensive ani-
mal studies showed that the b-adrenergic-dependent activation
of SNS through agents such as PPARc activators and thiazolidine-
diones induces BAT recruitment and/or enhances number of beige
adipocytes in rodent WAT [23,25,75,76]. However, human trials of
pharmaceutical agents stimulating BAT activity via b-adrenergic
signaling pathways have led to unsuccessful results due to lack
of efficacy or side effects accompanied the tested agents
[48,77,78]. Experimental studies in rodents and humans provide
evidence that the activation of b3-adrenergic receptors does not
represent the only pathway to stimulate BAT-mediated NST
[74,79]. Indeed, it seems that alternative pathways such as
TRPM8-mediated UCP1 activation associated to Ca2+-dependent
PKA phosphorylation [41], or other tissues, including the skeletal
muscle, can also stimulate NST, independently of SNS activation
[74]. Thus, it is evident that novel factors activating UCP1-
dependent thermogenesis in WAT depots as well as recruiting clas-
sical brown adipocytes may be identified.
Recent findings highlight the role of L-menthol-induced TRPM8
activation in UCP1-dependent thermogenesis, energy expenditure,
glucose homeostasis, and protection against diet-induced obesity,
promoting metabolic health [41]. The putative L-menthol-induced
metabolic adaptation of WAT to a functional thermogenic BAT-like
activity, independentlyof SNSstimulation, appears tobeapromising
therapeutic regimeto regulateenergyhomeostasis andbodyweight,
opening new avenues in treating individuals with obesity and its
relatedco-morbidities.Therefore, investigatingtheimpactofchronic
L-menthol dietary treatment on energy balance and systemic meta-
bolic homeostasis will shed light on the role of novel factors and
mechanismsforthepathophysiologyofobesityandthedevelopment
of novel and safe therapeutic strategies.
Concluding remarks
The development of novel and safe therapeutic strategies for
combating the global pandemic of obesity has become an urgent
issue to be addressed. To our knowledge, the impact of TRPM8
and TRPA1 activation in response to chronic L-menthol dietary
treatment on WAT thermogenic phenotype and metabolism in
obese and overweight individuals remains unknown. It is hoped
that, if our hypothesis was to be confirmed, the regulation of
energy balance and metabolic homeostasis by L-menthol-
dependent TRPM8 and/or TRPA1 activity could be therapeutically
exploited to prevent and/or treat obesity and its related co-
morbidities, promoting overall metabolic health.Conflict of interest statement
The authors report no financial and personal relationships with
other people or organisations that could inappropriately influence
(bias) their work. The sponsors of the work had no role or contri-
bution in the formulation of the hypothesis, the writing of the
manuscript, or in the decision to submit the manuscript for
publication.
Acknowledgments
This work was supported by funding from the European Union
7th Framework Program (FP7-PEOPLE-2013-IRSES Grant No.612547), the Education and Lifelong Learning Programme of the
Greek Ministry of Education, Co-financed by Greece and the Euro-
pean Union (NSRF 2007-2013, IRAKLITOS II, Grant No. 162), as well
as the Swedish federal government under the LUA/ALF agreement
(to PAS).References
[1] World Health Organization. Obesity and overweight, 2015. <http://www.who.
int/mediacentre/factsheets/fs311/en/> [accessed 22.9.15].
[2] Huntington MK, Shewmake RA. Weight-loss supplements: what is the
evidence? S D Med 2010;63:205–7.
[3] Bodimeade M. Global obesity market, 2013. <http://www.companiesandmar-
kets.com/MarketInsight/Healthcare-and-Medical/Global-Obesity-Market/NI69
63> [Accessed 22.9.15].
[4] Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global
trends in body-mass index since 1980: systematic analysis of health
examination surveys and epidemiological studies with 960 country-years
and 9.1 million participants. Lancet 2011;377:557–67.
[5] de Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight
and obesity among preschool children. Am J Clin Nutr 2010;92:1257–64.
[6] Mattson MP. Perspective: does brown fat protect against diseases of aging?
Ageing Res Rev 2010;9:69–76.
[7] Carrillo AE, Flouris AD. Caloric restriction and longevity: effects of reduced
body temperature. Ageing Res Rev 2011;10:153–62.
[8] Sidossis L, Kajimura S. Brown and beige fat in humans: thermogenic adipocytes
that control energy and glucose homeostasis. J Clin Invest 2015;125:478–86.
[9] Svensson PA, Jernas M, Sjoholm K, et al. Gene expression in human brown
adipose tissue. Int J Mol Med 2011;27:227–32.
[10] Harms M, Seale P. Brown and beige fat: development, function and therapeutic
potential. Nat Med 2013;19:1252–63.
[11] Wu J, Cohen P, Spiegelman BM. Adaptive thermogenesis in adipocytes: is beige
the new brown? Genes Dev 2013;27:234–50.
[12] Kajimura S, Saito M. A new era in brown adipose tissue biology: molecular
control of brown fat development and energy homeostasis. Annu Rev Physiol
2014;76:225–49.
[13] Petrovic N, Walden TB, Shabalina IG, Timmons JA, Cannon B, Nedergaard J.
Chronic peroxisome proliferator-activated receptor gamma (PPARgamma)
activation of epididymally derived white adipocyte cultures reveals a
population of thermogenically competent, UCP1-containing adipocytes
molecularly distinct from classic brown adipocytes. J Biol Chem
2010;285:7153–64.
[14] Bostrom P, Wu J, Jedrychowski MP, et al. A PGC1-alpha-dependent myokine
that drives brown-fat-like development of white fat and thermogenesis.
Nature 2012;481:463–8.
[15] Wu J, Bostrom P, Sparks LM, et al. Beige adipocytes are a distinct type of
thermogenic fat cell in mouse and human. Cell 2012;150:366–76.
[16] Cousin B, Cinti S, Morroni M, et al. Occurrence of brown adipocytes in rat white
adipose tissue: molecular and morphological characterization. J Cell Sci
1992;103(Pt. 4):931–42.
[17] Guerra C, Koza RA, Yamashita H, Walsh K, Kozak LP. Emergence of brown
adipocytes in white fat in mice is under genetic control. Effects on body weight
and adiposity. J Clin Invest 1998;102:412–20.
[18] Himms-Hagen J, Melnyk A, Zingaretti MC, Ceresi E, Barbatelli G, Cinti S.
Multilocular fat cells in WAT of CL-316243-treated rats derive directly from
white adipocytes. Am J Physiol Cell Physiol 2000;279:C670–81.
[19] Jankovic A, Korac A, Buzadzic B, et al. Endocrine and metabolic signaling in
retroperitoneal white adipose tissue remodeling during cold acclimation. J
Obes 2013;2013:937572.
[20] Jankovic A, Golic I, Markelic M, et al. Two key temporally distinguishable
molecular and cellular components of white adipose tissue browning during
cold acclimation. J Physiol 2015.
[21] Seale P, Bjork B, Yang W, et al. PRDM16 controls a brown fat/skeletal muscle
switch. Nature 2008;454:961–7.
[22] Xue Y, Petrovic N, Cao R, et al. Hypoxia-independent angiogenesis in adipose
tissues during cold acclimation. Cell Metab 2009;9:99–109.
[23] Fukui Y, Masui S, Osada S, Umesono K, Motojima K. A new thiazolidinedione,
NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic
effects and induces uncoupling protein 1 in white adipose tissue of KKAy
obese mice. Diabetes 2000;49:759–67.
[24] Laplante M, Sell H, MacNaul KL, Richard D, Berger JP, Deshaies Y. PPAR-gamma
activation mediates adipose depot-specific effects on gene expression and
lipoprotein lipase activity: mechanisms for modulation of postprandial
lipemia and differential adipose accretion. Diabetes 2003;52:291–9.
[25] Sell H, Berger JP, Samson P, et al. Peroxisome proliferator-activated receptor
gamma agonism increases the capacity for sympathetically mediated
thermogenesis in lean and ob/ob mice. Endocrinology 2004;145:3925–34.
[26] Wilson-Fritch L, Nicoloro S, Chouinard M, et al. Mitochondrial remodeling in
adipose tissue associated with obesity and treatment with rosiglitazone. J Clin
Invest 2004;114:1281–9.
[27] Carmona MC, Louche K, Lefebvre B, et al. S 26948: a new specific peroxisome
proliferator activated receptor gamma modulator with potent antidiabetes
and antiatherogenic effects. Diabetes 2007;56:2797–808.
26 P. Sakellariou et al. /Medical Hypotheses 93 (2016) 21–26[28] Rong JX, Qiu Y, Hansen MK, et al. Adipose mitochondrial biogenesis is
suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone.
Diabetes 2007;56:1751–60.
[29] Sutherland LN, Bomhof MR, Capozzi LC, Basaraba SA, Wright DC. Exercise and
adrenaline increase PGC-1{alpha} mRNA expression in rat adipose tissue. J
Physiol 2009;587:1607–17.
[30] Cao L, Choi EY, Liu X, et al. White to brown fat phenotypic switch induced by
genetic and environmental activation of a hypothalamic-adipocyte axis. Cell
Metab 2011;14:324–38.
[31] Trevellin E, Scorzeto M, Olivieri M, et al. Exercise training induces
mitochondrial biogenesis and glucose uptake in subcutaneous adipose tissue
through eNOS-dependent mechanisms. Diabetes 2014;63:2800–11.
[32] Stanford KI, Middelbeek RJ, Townsend KL, et al. A novel role for subcutaneous
adipose tissue in exercise-induced improvements in glucose homeostasis.
Diabetes 2015;64:2002–14.
[33] van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold-
activated brown adipose tissue in healthy men. N Engl J Med
2009;360:1500–8.
[34] Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in
healthy adults. N Engl J Med 2009;360:1518–25.
[35] Dinas PC, Nikaki A, Jamurtas AZ, et al. Association between habitual physical
activity and brown adipose tissue activity in individuals undergoing PET-CT
scan. Clin Endocrinol (Oxf) 2015;82:147–54.
[36] Flouris AD, Dinas PC. Impact of regular exercise on classical brown adipose
tissue. Clin Endocrinol (Oxf) 2015;83:591–3.
[37] Valente A, Jamurtas AZ, Koutedakis Y, Flouris AD. Molecular pathways linking
non-shivering thermogenesis and obesity: focusing on brown adipose tissue
development. Biol Rev Camb Philos Soc 2015;90:77–88.
[38] Pfannenberg C, Werner MK, Ripkens S, et al. Impact of age on the relationships
of brown adipose tissue with sex and adiposity in humans. Diabetes
2010;59:1789–93.
[39] Virtanen KA, Nuutila P. Brown adipose tissue in humans. Curr Opin Lipidol
2011;22:49–54.
[40] Tajino K, Matsumura K, Kosada K, et al. Application of menthol to the skin of
whole trunk in mice induces autonomic and behavioral heat-gain responses.
Am J Physiol Regul Integr Comp Physiol 2007;293:R2128–35.
[41] Ma S, Yu H, Zhao Z, et al. Activation of the cold-sensing TRPM8 channel triggers
UCP1-dependent thermogenesis and prevents obesity. J Mol Cell Biol
2012;4:88–96.
[42] Rossato M, Granzotto M, Macchi V, et al. Human white adipocytes express the
cold receptor TRPM8 which activation induces UCP1 expression,
mitochondrial activation and heat production. Mol Cell Endocrinol
2014;383:137–46.
[43] Eccles R. Menthol and related cooling compounds. J Pharm Pharmacol
1994;46:618–30.
[44] Vriens J, Nilius B, Vennekens R. Herbal compounds and toxins modulating TRP
channels. Curr Neuropharmacol 2008;6:79–96.
[45] McKemy DD, Neuhausser WM, Julius D. Identification of a cold receptor
reveals a general role for TRP channels in thermosensation. Nature
2002;416:52–8.
[46] Peier AM, Moqrich A, Hergarden AC, et al. A TRP channel that senses cold
stimuli and menthol. Cell 2002;108:705–15.
[47] Nealen ML, Gold MS, Thut PD, Caterina MJ. TRPM8 mRNA is expressed in a
subset of cold-responsive trigeminal neurons from rat. J Neurophysiol
2003;90:515–20.
[48] Collins S, Cao W, Robidoux J. Learning new tricks from old dogs: beta-
adrenergic receptors teach new lessons on firing up adipose tissue
metabolism. Mol Endocrinol 2004;18:2123–31.
[49] Cinti S. Transdifferentiation properties of adipocytes in the adipose organ. Am J
Physiol Endocrinol Metab 2009;297:E977–86.
[50] Seale P, Conroe HM, Estall J, et al. Prdm16 determines the thermogenic
program of subcutaneous white adipose tissue in mice. J Clin Invest
2011;121:96–105.
[51] Lim S, Honek J, Xue Y, et al. Cold-induced activation of brown adipose tissue
and adipose angiogenesis in mice. Nat Protoc 2012;7:606–15.
[52] Zygmunt PM, Hogestatt ED. TRPA1. Handb Exp Pharmacol 2014;222:583–630.
[53] Karashima Y, Damann N, Prenen J, et al. Bimodal action of menthol on the
transient receptor potential channel TRPA1. J Neurosci 2007;27:9874–84.
[54] Xiao B, Dubin AE, Bursulaya B, Viswanath V, Jegla TJ, Patapoutian A.
Identification of transmembrane domain 5 as a critical molecular
determinant of menthol sensitivity in mammalian TRPA1 channels. J
Neurosci 2008;28:9640–51.[55] Gentry C, Stoakley N, Andersson DA, Bevan S. The roles of iPLA2, TRPM8 and
TRPA1 in chemically induced cold hypersensitivity. Mol Pain 2010;6:4.
[56] Knowlton WM, Bifolck-Fisher A, Bautista DM, McKemy DD. TRPM8, but not
TRPA1, is required for neural and behavioral responses to acute noxious cold
temperatures and cold-mimetics in vivo. Pain 2010;150:340–50.
[57] Macpherson LJ, Hwang SW, Miyamoto T, Dubin AE, Patapoutian A, Story GM.
More than cool: promiscuous relationships of menthol and other sensory
compounds. Mol Cell Neurosci 2006;32:335–43.
[58] Olsen RV, Andersen HH, Moller HG, Eskelund PW, Arendt-Nielsen L.
Somatosensory and vasomotor manifestations of individual and combined
stimulation of TRPM8 and TRPA1 using topical L-menthol and trans-
cinnamaldehyde in healthy volunteers. Eur J Pain 2014;18:1333–42.
[59] Chen J, Kang D, Xu J, et al. Species differences and molecular determinant of
TRPA1 cold sensitivity. Nat Commun 2013;4:2501.
[60] Bianchi BR, Zhang XF, Reilly RM, Kym PR, Yao BB, Chen J. Species comparison
and pharmacological characterization of human, monkey, rat, and mouse
TRPA1 channels. J Pharmacol Exp Ther 2012;341:360–8.
[61] Tajino K, Hosokawa H, Maegawa S, Matsumura K, Dhaka A, Kobayashi S.
Cooling-sensitive TRPM8 is thermostat of skin temperature against cooling.
PLoS ONE 2011;6:e17504.
[62] Romanovsky AA. Skin temperature: its role in thermoregulation. Acta Physiol
(Oxf) 2014;210:498–507.
[63] Flouris AD, Schlader ZJ. Human behavioral thermoregulation during exercise in
the heat. Scand J Med Sci Sports 2015;25(Suppl. 1):52–64.
[64] Voets T, Talavera K, Owsianik G, Nilius B. Sensing with TRP channels. Nat Chem
Biol 2005;1:85–92.
[65] Eisenberg Jr F, Field JB, Stetten Jr D. Studies on glucuronide conjugation in man.
Arch Biochem Biophys 1955;59:297–9.
[66] Gagge AP, Stolwijk JA, Saltin B. Comfort and thermal sensations and associated
physiological responses during exercise at various ambient temperatures.
Environ Res 1969;2:209–29.
[67] Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental
variables approach. J Health Econ 2012;31:219–30.
[68] Grover SA, Kaouache M, Rempel P, et al. Years of life lost and healthy life-years
lost from diabetes and cardiovascular disease in overweight and obese people:
a modelling study. Lancet Diabetes Endocrinol 2015;3:114–22.
[69] Cypess AM, Lehman S, Williams G, et al. Identification and importance of
brown adipose tissue in adult humans. N Engl J Med 2009;360:1509–17.
[70] Orava J, Nuutila P, Lidell ME, et al. Different metabolic responses of human
brown adipose tissue to activation by cold and insulin. Cell Metab
2011;14:272–9.
[71] Yoneshiro T, Aita S, Matsushita M, et al. Brown adipose tissue, whole-body
energy expenditure, and thermogenesis in healthy adult men. Obesity (Silver
Spring) 2011;19:13–6.
[72] Ouellet V, Labbe SM, Blondin DP, et al. Brown adipose tissue oxidative
metabolism contributes to energy expenditure during acute cold exposure in
humans. J Clin Invest 2012;122:545–52.
[73] Vijgen GH, Bouvy ND, Teule GJ, et al. Increase in brown adipose tissue activity
after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2012;97.
E1229-33.
[74] Vosselman MJ, van der Lans AA, Brans B, et al. Systemic beta-adrenergic
stimulation of thermogenesis is not accompanied by brown adipose tissue
activity in humans. Diabetes 2012;61:3106–13.
[75] Pardo R, Enguix N, Lasheras J, Feliu JE, Kralli A, Villena JA. Rosiglitazone-
induced mitochondrial biogenesis in white adipose tissue is independent of
peroxisome proliferator-activated receptor gamma coactivator-1alpha. PLoS
ONE 2011;6:e26989.
[76] Ohno H, Shinoda K, Spiegelman BM, Kajimura S. PPARgamma agonists induce a
white-to-brown fat conversion through stabilization of PRDM16 protein. Cell
Metab 2012;15:395–404.
[77] Redman LM, de Jonge L, Fang X, et al. Lack of an effect of a novel beta3-
adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a
double-blind, placebo-controlled randomized study. J Clin Endocrinol Metab
2007;92:527–31.
[78] Whittle AJ, Lopez M, Vidal-Puig A. Using brown adipose tissue to treat obesity
– the central issue. Trends Mol Med 2011;17:405–11.
[79] Lehr L, Canola K, Asensio C, et al. The control of UCP1 is dissociated from that of
PGC-1alpha or of mitochondriogenesis as revealed by a study using beta-less
mouse brown adipocytes in culture. FEBS Lett 2006;580:4661–6.
